Riyadh Cement Valuation
Is 3092 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3092 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3092 (SAR26.05) is trading below our estimate of fair value (SAR32.16)
Significantly Below Fair Value: 3092 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3092?
Other financial metrics that can be useful for relative valuation.
What is 3092's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ر.س3.11b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.5x |
Enterprise Value/EBITDA | 9.3x |
PEG Ratio | 3.2x |
Price to Earnings Ratio vs Peers
How does 3092's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 20.8x | ||
3010 Arabian Cement | 17.2x | 10.7% | ر.س2.5b |
3060 Yanbu Cement | 28.9x | 28.8% | ر.س3.8b |
3080 Eastern Province Cement | 12.4x | -1.2% | ر.س2.8b |
3003 City Cement | 24.5x | 18.0% | ر.س2.5b |
3092 Riyadh Cement | 15.9x | 4.9% | ر.س3.1b |
Price-To-Earnings vs Peers: 3092 is good value based on its Price-To-Earnings Ratio (15.9x) compared to the peer average (20.8x).
Price to Earnings Ratio vs Industry
How does 3092's PE Ratio compare vs other companies in the SA Basic Materials Industry?
Price-To-Earnings vs Industry: 3092 is good value based on its Price-To-Earnings Ratio (15.9x) compared to the Asian Basic Materials industry average (16.3x).
Price to Earnings Ratio vs Fair Ratio
What is 3092's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 15.9x |
Fair PE Ratio | 18.4x |
Price-To-Earnings vs Fair Ratio: 3092 is good value based on its Price-To-Earnings Ratio (15.9x) compared to the estimated Fair Price-To-Earnings Ratio (18.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | ر.س26.05 | ر.س31.57 +21.2% | 9.3% | ر.س35.70 | ر.س29.00 | n/a | 3 |
Aug ’25 | ر.س24.78 | ر.س31.57 +27.4% | 9.3% | ر.س35.70 | ر.س29.00 | n/a | 3 |
Jul ’25 | ر.س25.40 | ر.س33.43 +31.6% | 12.3% | ر.س39.00 | ر.س29.00 | n/a | 4 |
Jun ’25 | ر.س26.70 | ر.س33.43 +25.2% | 12.3% | ر.س39.00 | ر.س29.00 | n/a | 4 |
May ’25 | ر.س27.50 | ر.س33.90 +23.3% | 13.1% | ر.س39.00 | ر.س29.00 | n/a | 4 |
Apr ’25 | ر.س28.60 | ر.س35.53 +24.2% | 11.1% | ر.س39.00 | ر.س30.00 | n/a | 3 |
Mar ’25 | ر.س28.85 | ر.س35.53 +23.2% | 11.1% | ر.س39.00 | ر.س30.00 | n/a | 3 |
Feb ’25 | ر.س28.95 | ر.س35.53 +22.7% | 11.1% | ر.س39.00 | ر.س30.00 | n/a | 3 |
Jan ’25 | ر.س34.00 | ر.س36.87 +8.4% | 5.7% | ر.س39.00 | ر.س34.00 | n/a | 3 |
Dec ’24 | ر.س34.80 | ر.س35.57 +2.2% | 4.2% | ر.س37.60 | ر.س34.00 | n/a | 3 |
Nov ’24 | ر.س29.60 | ر.س35.57 +20.2% | 4.2% | ر.س37.60 | ر.س34.00 | n/a | 3 |
Oct ’24 | ر.س32.00 | ر.س35.57 +11.1% | 4.2% | ر.س37.60 | ر.س34.00 | n/a | 3 |
Sep ’24 | ر.س32.70 | ر.س35.57 +8.8% | 4.2% | ر.س37.60 | ر.س34.00 | n/a | 3 |
Aug ’24 | ر.س33.65 | ر.س35.57 +5.7% | 4.2% | ر.س37.60 | ر.س34.00 | ر.س24.78 | 3 |
Jul ’24 | n/a | ر.س35.57 0% | 4.2% | ر.س37.60 | ر.س34.00 | ر.س25.40 | 3 |
Jun ’24 | ر.س31.00 | ر.س32.10 +3.5% | 5.9% | ر.س34.00 | ر.س30.20 | ر.س26.70 | 2 |
May ’24 | ر.س32.50 | ر.س32.10 -1.2% | 5.9% | ر.س34.00 | ر.س30.20 | ر.س27.50 | 2 |
Apr ’24 | ر.س32.00 | ر.س32.10 +0.3% | 5.9% | ر.س34.00 | ر.س30.20 | ر.س28.60 | 2 |
Mar ’24 | ر.س30.35 | ر.س32.10 +5.8% | 5.9% | ر.س34.00 | ر.س30.20 | ر.س28.85 | 2 |
Feb ’24 | ر.س31.90 | ر.س32.10 +0.6% | 5.9% | ر.س34.00 | ر.س30.20 | ر.س28.95 | 2 |
Jan ’24 | ر.س31.00 | ر.س33.10 +6.8% | 8.8% | ر.س36.00 | ر.س30.20 | ر.س34.00 | 2 |
Nov ’23 | ر.س32.25 | ر.س38.70 +20.0% | 5.9% | ر.س41.60 | ر.س36.00 | ر.س29.60 | 3 |
Oct ’23 | ر.س32.00 | ر.س38.70 +20.9% | 5.9% | ر.س41.60 | ر.س36.00 | ر.س32.00 | 3 |
Sep ’23 | ر.س34.95 | ر.س39.23 +12.2% | 4.5% | ر.س41.60 | ر.س36.80 | ر.س32.70 | 4 |
Aug ’23 | ر.س33.40 | ر.س39.23 +17.4% | 4.5% | ر.س41.60 | ر.س36.80 | ر.س33.65 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.